Mehta declines Gujarat Lokayukta's post, blasts Modi govt

August 7, 2013
Ahmedabad, Aug 7: Justice R A Mehta, whose appointment as Gujarat Lokayukta was opposed by Narendra Modi, today declined to assume office, saying the controversy has "denigrated" the office of the anti-corruption watchdog. guj

A retired Gujarat High Court judge, Mehta, blasted the Modi government for calling him "biased" and "anti-government" while opposing his appointment.

A Lokayukta unwanted by the government cannot get all the necessary and timely support from it, he said in a letter to Gujarat Governor Kamla Beniwal who had appointed him, triggering a standoff with the Modi government.

Maintaining that the "appointment has lost all the grace and dignity", the former judge said he was withdrawing his consent as "he could not persuade himself to accept the office of Lokayukta".

"I humbly withdraw my consent for the appointment as the Gujarat Lokayukta and decline to assume the office. Kindly accept my request and relieve me," Mehta said in his 7-page letter.

"I am averse to any controversy and try to keep away. The present controversy has denigrated the office of the Lokayukta and adversely affected its credibility. The appointment has lost all the grace and dignity," he said.

By-passing the state government, Governor Beniwal had appointed Mehta as Lokayukta on August 25, 2011. This was followed by a legal battle which lasted almost two years as state government sought to overturn his appointment and contested it till the last remedy of a curative petition was rejected by the Supreme Court.

Assailing the Modi government, Mehta said, "The objection alleging anti-government bias (though negatived by the courts), really hurts. Some think that if a person is not pro-government, he is necessarily anti-government. They can't accept that there is third category, neither pro nor anti, but independent and neutral. Their mindset is clear- their way or no other way."

Mehta has also cited Gujarat government's "reluctance" to notify his appointment in the state gazette even after its three petitions were rejected by the apex court.

"Even after three judgements of the Supreme Court, the reluctance of the State Government to notify the Lokayukta appointment in the official Gujarat Government gazette is surprising, but not unexpected," he wrote.

"I frankly admit that I will not be able to fulfil the public duty, public need and high public expectation from the Lokayukta in the circumstances.

"How can I take the responsibility and become the Lokayukta when my objectivity and credibility are not accepted by the government and by the public functionaries whose conduct the Lokayukta may have to investigate? Findings and recommendations - for or against a public functionary- will always be under question mark," Mehta said. Mehta also criticised the Gujarat Lokayukta Bill 2013 passed by the state Assembly in April which allows a six member committee headed by the Chief Minister to choose the Lokayukta.

"Giving a voice and primacy to such public functionaries to decide, who is to be their investigator, would give an impression that they want it to be their 'caged parrot' and the institution of the Lokayukta would lose all credibility and respect of the people and deter many judges from accepting," he said.

Mehta lamented the way the state government invited him to take charge of Lokayukta office after the Supreme Court judgment on its curative petition was rejected.

"The letter of the Gujarat government dated July 26, 2013 (delivered at my Ahmedabad residence while I was in USA) does not indicate any invitation or interest by the government. As if the government has no interest or role in the matter...no invitation and no notification by the government!," he said.

"Persistently and tenaciously approaching the Supreme Court (SLP, Review Petition, and Curative Petition) at huge public expense. It may be compared to the budget for the Lokayukta office or even of the High Court (which deals with lakhs of cases every year). It would be an eye-opener," he wrote, blaming the Modi government for his decision.

He also complained about state government's "non-cooperation" to provide enough infrastructure and budgetary support for the Lokayukta office.

"If the Lokayukta has to depend on the reluctant non-cooperative government for all infrastructure, staff, budget etc, and to beg or fight for it, it is not in my nature. In this scenario, the Lokayukta will not able to function effectively and to fulfil the high public expectations," he said.

Comments

Add new comment

  • Coastaldigest.com reserves the right to delete or block any comments.
  • Coastaldigset.com is not responsible for its readers’ comments.
  • Comments that are abusive, incendiary or irrelevant are strictly prohibited.
  • Please use a genuine email ID and provide your name to avoid reject.
News Network
July 16,2020

New Delhi, Jul 16: India's pharmaceutical industry will be able to produce Covid-19 vaccines not just for the country but also for the entire world, according to Microsoft co-founder and philanthropist Bill Gates.

A lot of "very important things have been done" in India and its pharma industry is doing work "to help make the coronavirus vaccine building on other great capacities that they have used for other diseases", said the Co-Chair and Trustee of Bill and Melinda Gates Foundation.

Speaking in a documentary -- Covid-19: India's War Against The Virus -- to be premiered on Discovery Plus this (Thursday) evening, Gates said India also faces a huge challenge due to the health crisis because of its gigantic size and urban centres with a lot of population density.

Commenting on the strength of India's pharma industry, he said, "India has a lot of capacity there -- with the drug and vaccine companies that are huge suppliers to the entire world. You know, more vaccines are made in India than anywhere-- starting with Serum Institute, that's the largest."

He further said, "But (there are) also Bio E, Bharat (Biotech), many others. They are doing work to help make the coronavirus vaccine, building on other great capacities that they have used for other diseases."

Stating that India joined Coalition for Epidemic Preparedness Innovations (CEPI), which is a group working on a global basis to build vaccines platforms, Gates said, "I am excited that the pharmaceutical industry there will be able to produce not just for India but also for the entire world. (This is) What we need to reduce the deaths and make sure we are immune, which is how we end the epidemic."

Gates said Bill and Melinda Gates Foundation is also a "partner with the government, particularly with the department of biotechnology, the Indian Council of Medical Research (ICMR) and the office of the principal scientific advisor provide advice and help about getting these tools going".

Commenting on the deadly virus breaching India's borders in the documentary which was shot extensively during the period of lockdown, he said, "India is still at the beginning of this, but there's a lot of very important things have been done.

“It's a huge challenge with India because you've got a gigantic country. You've got your urban centers with a lot of density-- and so that-- drives the spread. You have people moving around."

He, however, added: "Yet people are stepping up... Looking at how we reduce the spread while trying not to reduce food availability, equipment that people need."

Highlighting Gates foundation's role, he said it has "worked for the Indian government on health issues like introducing new vaccines over the last decade; and so when Covid-19 came along, we stepped in and said you know where are the gaps, we have been funding work on detection and isolation.

“We have been particularly active in UP and Bihar where we have done health delivery in the past."

The foundation is also working with the department of personnel and training to take their online training platforms and "are now using that guidance to help their frontline health workers", Gates said. 

Comments

Add new comment

  • Coastaldigest.com reserves the right to delete or block any comments.
  • Coastaldigset.com is not responsible for its readers’ comments.
  • Comments that are abusive, incendiary or irrelevant are strictly prohibited.
  • Please use a genuine email ID and provide your name to avoid reject.
News Network
March 29,2020

Mumbai, Mar 29: Virologist Minal Dakhave Bhosale led from the front to create India's first coronavirus testing kit even when she was in the last stage of her pregnancy.

Bhosale's efforts paid the price with her team delivering the testing kit in a record time of six weeks.

Bhosale gave birth to a baby girl just a day before submitting the kit to the authorities for evaluation.

"It was like giving birth to two babies," Bhosale told PTI over the phone.

The virologist said both the journeys - that happened in parallel - were not without challenges.

"There were complications in the pregnancy while work on the test kit was on. The baby was delivered through cesarean," she said.

Bhosale said she felt that it was the right time to serve the people to help them in combating the coronavirus threat.

"I had been working for five years in this field and if I don't work in emergency situations when my services are needed the most, then what is the use?" she said.

Though Bhosale was not able to visit the office due to the pregnancy, she was guiding a team of 10 persons working on the project at Mylab Discovery in Pune.

The strong bonds forged with the team over the years and their support made it possible, she said.

Company's co-founder Shrikant Patole said just like drug discovery, test kits too go through a lot of quality checks to improve the precision.

He credited Bhosale for the success of the project.

The COVID-19 testing kit delivered by Bhosale's team will reduce the time taken for delivering a result to 2.5 hours from the prevalent practice of eight hours.

A pioneering approach to testing without compromising on the results was adopted, Bhosale said.

The Maylab test kit will cost Rs1,200, a quarter of Rs 4,500 per kit that the government has been spending on testing so far.

"I'm happy that I could do something for the country," Bhosale said.

As of Friday, only 27,000 of the 1.3 billion people were tested for the virus in the country.

According to experts, high scale testing is essential because it alone can ensure an early diagnosis of COVID-19 and lower down the fatalities.

The company is confident of ramping up the capacity at its plant in Lonavala to deliver 100,000 kits a week, Patole said.

He said the authorities are helping the company, including giving priority for shipping of the raw materials.

Comments

Add new comment

  • Coastaldigest.com reserves the right to delete or block any comments.
  • Coastaldigset.com is not responsible for its readers’ comments.
  • Comments that are abusive, incendiary or irrelevant are strictly prohibited.
  • Please use a genuine email ID and provide your name to avoid reject.
News Network
June 24,2020

Kolkata, Jun 24: Trinamool Congress (TMC) MLA Tamonash Ghosh, who had tested positive for Covid-19 in May, died at a hospital here on Wednesday, party sources said.

He was 60.

The three-time MLA from the Falta assembly constituency in South 24 Parganas district was admitted to a hospital after he tested positive for the disease, they said.

He had several complications related to the heart and the kidney, the sources said.

"Very, very sad. Tamonash Ghosh, 3-time MLA from Falta & party treasurer since 1998 had to leave us today. Been with us for over 35 years, he was dedicated to the cause of the people & party. He contributed much through his social work," West Bengal Chief Minister and TMC supremo Mamata Banerjee tweeted.

"He has left a void that will be difficult to fill. On behalf of all of us, heartfelt condolences to his wife Jharna, his two daughters, friends and well-wishers," she added.

Comments

Add new comment

  • Coastaldigest.com reserves the right to delete or block any comments.
  • Coastaldigset.com is not responsible for its readers’ comments.
  • Comments that are abusive, incendiary or irrelevant are strictly prohibited.
  • Please use a genuine email ID and provide your name to avoid reject.